To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Lee is the founder and managing director of Cell Therapy Group – a leading, boutique consultancy focused on the cell therapy and regenerative medicine industry.
Through CTG Lee works with companies of all sizes to help position them in the cell therapy regenerative medicine space by focusing on business development including strategy development, competitive intelligence, market research and analysis, deal-making, marketing and communications, profile-building, sale-lead generation, etc.
The core value Lee brings to CTG and its clients is a rare breadth of understanding of the entire spectrum of the cell therapy and regenmed industries primarily around who is doing what with whom. This knowledge of the
industry players, what they have, and with whom they are working is both driven by and drives his proprietary industry database. Additionally, Lee leverages for his clients the relationships he has with executives in many of those companies and an extensive social media network.
Lee is also the co-founder, partner and Managing Director of RegenerativeMedicineJobs.com, an online job board and social recruiting system for employers and job seekers in the regenerative medicine industry.
Since early 2000, Lee has been an executive in the cell-based regenerative medicine industry. He has significant experience in both for-profit companies and non-profit organizations including Progenitor Cell Therapy, Malachite Management, Stem Cell Technologies, and the International Society for Cellular Therapy.
Before transitioning to biotech, Lee earned a law degree (cum laude) and was a practicing commercial attorney for several years.
Lee founded Cell Therapy News, created Cell Therapy Blog where he continues to blog, and serves on the editorial advisory boards of the journals BioProcess International and Regenerative Medicine.
Lee founded and served as Chair of ISCT's Cell Therapy Commercialization Committee (2006-9), founded and administers the LinkedIn Cell Therapy Industry Group, serves as an advisory board to the Student Society for Stem Cell Research (SSCR), and has served as an advisor to dozens of groups and projects in the regenerative medicine space.
Lee is a frequently invited speaker and moderator at conferences in the industry. He is also an invited guest blogger for the newly combined blog of the Canadian Stem Cell Network and the Canadian Centre for Regenerative Medicine (CCRM) entitled, “Signals”.
Recent publications include a book chapter entitled, “State of the Regenerative Medicine Industry” in The Delivery of Regenerative Medicines and Their Impact on Healthcare (CRC Press) and “Opportunities in Regenerative Medicine: The Global Industry and Market Trends” in BioProcess International, March 2011 Supplement. He has recently accepted an invitation to co-authored a book chapter entitled “Financing strategies for regenerative medicine production and technology development startups”.
Stocks - long, Stocks - short
Cell Therapy Group
Cell therapy group provides companies in the cell-based regenerative medicine sector with a wide range of technical, scientific and commercial expertise. Cell Therapy Group (CTG) was founded in June 2008 by Lee Buckler to meet the demand for business-focused services by those with expertise in regenerative
medicine and cell therapy industries as well as the use of cells in traditional drug development. CTG's clients benefit from working with experienced consultants each having significant corporate, commercial technical and/or scientific expertise in cell-based regenerative medicine Clients: therapeutic, device, service, tools, and reagent companies, pharmaceutical companies, investors, publishers, other consultants, etc Services: commercial-related services such as business development, market analysis & research, marketing, strategic planning, due diligence licensing, business planning, strategic alliances, sales & lead generation, advertising, project & interim management as well as more technical and scientific services such as basic research design, process & product development, cell expansion and differentiation protocols, modeling for stem cells in drug discovery and testing, etc. The Group Cell Therapy Group prides itself in an unparalleled breadth of knowledge of the cell therapy and regenmed industries with scientific, technical, and commercial expertise CTG has works for a wide range of clientele from very early-stage start-ups to some of the largest life science companies in the world. CTG has three categories of team members: Core Consultants who are senior consultants and project managers exclusive to CTG. Project Consultants under master services agreements and confidentiality agreements with CTG. They offer a wide variety of expertise and experience. They are brought in on projects as required. Consulting Network includes other consultancies with which we work closely as client needs and projects dictate.
Cell Therapy Blog
The blog covers the cell therapy industry. I don't typically cover the basic research news - there are others that do that well. I focus on industry news and content related to companies with technologies in the cell therapy space including regenerative medicine, tissue engineering, and gene therapy where
those involve cell ex vivo. I also don't typically cover the cells-as-tools space. (e.g., stem cells for discovery or toxicity testing). I welcome your feedback, comments, and content. Enjoy.
Currently, there are no book details for lbuckler.
A couple clarifications;Hea...
Weighing The Benefits Of Osiris' First Cell The...
Great piece. Well researche...
New Okyanos Heart Institute Makes Big Bet On Cy...
Xignite quote data
© 2014 Seeking Alpha